L. Masana

1985–2025 年に発表

103
論文数
24,974
被引用数
55
h 指数
94
i10 指数

被引用数

L. Masana の年別被引用数1972 年: 被引用 1 件1990 年: 被引用 4 件1991 年: 被引用 3 件1992 年: 被引用 3 件1993 年: 被引用 4 件1994 年: 被引用 4 件1995 年: 被引用 3 件1996 年: 被引用 1 件1997 年: 被引用 2 件1998 年: 被引用 3 件1999 年: 被引用 2 件2000 年: 被引用 3 件2001 年: 被引用 6 件2002 年: 被引用 13 件2003 年: 被引用 26 件2004 年: 被引用 26 件2005 年: 被引用 29 件2006 年: 被引用 18 件2007 年: 被引用 23 件2008 年: 被引用 18 件2009 年: 被引用 24 件2010 年: 被引用 19 件2011 年: 被引用 61 件2012 年: 被引用 101 件2013 年: 被引用 138 件2014 年: 被引用 165 件2015 年: 被引用 202 件2016 年: 被引用 299 件2017 年: 被引用 206 件2018 年: 被引用 181 件2019 年: 被引用 795 件2020 年: 被引用 816 件2021 年: 被引用 939 件2022 年: 被引用 799 件2023 年: 被引用 665 件2024 年: 被引用 954 件2025 年: 被引用 499 件2026 年: 被引用 42 件1973〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,673 件、この内訳の 15.7%中国: 引用元論文 790 件、この内訳の 7.4%イギリス: 引用元論文 755 件、この内訳の 7.1%イタリア: 引用元論文 646 件、この内訳の 6.1%スペイン: 引用元論文 491 件、この内訳の 4.6%カナダ: 引用元論文 466 件、この内訳の 4.4%ドイツ: 引用元論文 453 件、この内訳の 4.2%オランダ: 引用元論文 416 件、この内訳の 3.9%オーストラリア: 引用元論文 382 件、この内訳の 3.6%フランス: 引用元論文 362 件、この内訳の 3.4%ポーランド: 引用元論文 243 件、この内訳の 2.3%デンマーク: 引用元論文 236 件、この内訳の 2.2%
0%15.7%その他 35.1%

分野

  • Medicine74.9%
  • Biochemistry, Genetics and Molecular Biology14.9%
  • Immunology and Microbiology3.1%
  • Nursing2.4%
  • Agricultural and Biological Sciences0.9%
  • Environmental Science0.6%
  • その他3.2%

トピック

  • Lipoproteins and Cardiovascular Health16.5%
  • Diabetes, Cardiovascular Risks, and Lipoproteins10.1%
  • Cancer, Lipids, and Metabolism3.9%
  • Atherosclerosis and Cardiovascular Diseases3.7%
  • Cholesterol and Lipid Metabolism3.3%
  • Lipid metabolism and disorders3%
  • その他59.5%

共著者

全論文

検索で開く
  1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2017 被引用: 3,840

  2. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2020 被引用: 1,527

  3. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , the DA VINCI study - European Journal of Preventive Cardiology 2020 被引用: 767

  4. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2013 被引用: 2,737

  5. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    著者: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2023 被引用: 331

  6. Lipoprotein(a) as a cardiovascular risk factor: current status

    著者: , , , , , , , , , , , , , , , , , , - European Heart Journal 2010 被引用: 1,795

  7. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anne Tybjærg‐Hansen, Olov Wiklund - European Heart Journal 2015 被引用: 870

  8. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , for the European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia, M. Cuchel, Éric Bruckert, M. John Chapman, O. S. Descamps, H. N. Ginsberg, Robert A. Hegele, Jan Albert Kuivenhoven, B. G. Nordestgaard, F. J. Raal, R. D. Santos, E. Steinhagen-Thiessen, Anne Tybjærg‐Hansen, Gerald F. Watts, M. John Chapman, Henry N. Ginsberg, Maurizio Averna, Cathérine Boileau, J. Boren, Alberico L. Catapano, Joep C. Defesche, G. K. Hovingh, Steve E. Humphries, Petri T. Kovanen, L. Masana, P. Pajukanta, Klaus G. Parhofer, Kausik K. Ray, Anton F. H. Stalenhoef, Erik S.G. Stroes, Marja‐Riitta Taskinen, Albert Wiegman, Olov Wiklund - European Heart Journal 2014 被引用: 1,053

  9. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R. Hobbs, Arno W. Hoes, Patricia M. Kearney, Juhani Knuuti, Philippe Kolh, T. McDonagh, Bruno Moulin, D Poldermans, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, P. A. Sirnes, Michał Tendera, Adam Torbicki, P. Vardas, P. Widimsky, Stephan Windecker, Document Reviewers, Christian Funck‐Brentano, D Poldermans, G. Berkenboom, Jacqueline de Graaf, Olivier Descamps, Nina Gotcheva, K. Griffith, Giuseppe Guida, S. Gulec, Y Henkin, Kurt Huber, Y. Antero Kesäniemi, J. Lekakis, Athanasios Manolis, Pedro Marques‐Vidal, L. Masana, John J.V. McMurray, Eugénia Mendes, Zurab Pagava, Terje Pedersen, Eva Prescott, Quitéria Rato, Giuseppe Rosano, Susana Sans, A. Stalenhoef, Lâle Tokgözoğlu, Margus Viigimaa, M. E. Wittekoek, José Luis Zamorano - European Heart Journal 2011 被引用: 3,547

  10. Combination lipid-lowering therapy as first-line strategy in very high-risk patients

    著者: , , , , , , , , , , - European Heart Journal 2021 被引用: 205

  11. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

    著者: , , , , , , , , , , , , , , , , , , , - European Heart Journal 2011 被引用: 1,227

  12. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2013 被引用: 634

  13. Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease

    著者: , , , , , , , , , , , , , , , , , , , , - Atherosclerosis 2013 被引用: 517

  14. Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

    著者: , , , , , , , , , , , , , , , , , - Atherosclerosis 2021 被引用: 136

  15. HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk

    著者: , , , , , , , , , - International Journal of Molecular Sciences 2019 被引用: 106

  16. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy

    著者: , , , , , , , , , , - Journal of Lipid Research 2015 被引用: 198

  17. Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges

    著者: , , , , - Heart 2021 被引用: 106

  18. The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5

    著者: , , , - Molecular and Cellular Endocrinology 2017 被引用: 128

  19. Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease

    著者: , , , , - Biomedicines 2022 被引用: 39

  20. Low HDL and high triglycerides predict COVID-19 severity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Glòria Vives-Masdeu, Carmen Arto-Fernández, Omar El Boutrouki, Andrea Vázquez-Escobales, Maria Cristina Antón-Alonso, Sergio Rivero-Santana, A Michavila Gómez, Sara L. Garcia, Núria Rial-Lorenzo, Lourdes Ruiz‐Ortega, Oriol Alonso-Gisbert, Ana Inés Méndez-Martínez, Hada Iglesias-López, Elisenda Climent, Robert Güerri‐Fernández, Jade Soldado, Marta Fanlo‐Maresma, Alicia Taboada, Liliana Gutiérrez-Carrasquilla - Scientific Reports 2021 被引用: 197

  21. Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short‐chain fatty acids

    著者: , , , , , , - IUBMB Life 2008 被引用: 119

  22. Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets

    著者: , , - Current Cardiology Reports 2020 被引用: 55

  23. Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

    著者: , , , , , , , , , , , , , , , - Cardiovascular Diabetology 2025 被引用: 29

  24. LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Research 2020 被引用: 65